Ali Behbahani

Director, CRISPR Therapeutics AG; Director, 10% owner, SpyGlass Pharma, Inc.

Bought, 12 months

$15.0M

Sold, 12 months

$0.8M

Companies

Latest trade

Sep 17, 2026

Companies

CRISPR Therapeutics AGDirector −$0.8M SpyGlass Pharma, Inc.Director, 10% owner +$15.0M

Trades

CRSP Sold 13,679 shares at $57.09 $0.8M Sep 17

SGP Bought 937,500 shares at $16.00 $15.0M Feb 9

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.